Silihan lan utang jangka dawa perusahaan celularity.com (CELU)

Celularity Inc. is recognized as an authoritative innovator in the field of tissue regeneration. The business relies on patented placental cell cultivation methods for organ restoration. This daily price chart reflects long-term debt, which stands at 0.00. Production stability is ensured by its own sterile complex in New Jersey with independent power supply for the bioreactors.

This indicator captures total liabilities with maturities exceeding twelve months, directly determining the net asset value through the difference between equity and liabilities. By analyzing the business's long-term debt, an investor assesses the financial stability of Celularity Inc. (CELU) during the implementation of costly developments in placenta-based allogeneic cell therapies for the treatment of oncology and age-related pathologies.